Suzanne Darby

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

John P. Neoptolemos, Daniel H. Palmer, Paula Ghaneh et al. · The Lancet · 2017 · 1.9K citations · Full text

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

John Primrose, Richard Fox, Daniel H. Palmer et al. · The Lancet Oncology · 2019 · 1.2K citations · Full text

Surgical Oncology, Gastrointestinal Oncology, Medicine +10

Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial

David Cunningham, Sally Stenning, Elizabeth Smyth et al. · The Lancet Oncology · 2017 · 282 citations · Full text

Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma

Robert Jones, Eftychia‐Eirini Psarelli, Richard Jackson et al. · JAMA Surgery · 2019 · 256 citations · Full text

A multicentre comparison between Child Pugh and Albumin‐Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma

Julien Edeline, Jean‐Frédéric Blanc, Philip J. Johnson et al. · Liver International · 2016 · 92 citations · Full text